In her latest blog Professor Anne Barton, Director of Manchester BRC, shares what we are doing to advance discoveries that improve the health and wellbeing of children and young people.
A team of international clinical experts, including Manchester BRC researcher Dr Riina Rautemaa-Richardson, have published the new global guideline for the diagnosis and treatment of Candida infections.
Five Manchester BRC bioinformaticians have shared what they learned from the European Conference on Computational Biology and how they are now applying this to their work analysing medical research data.
New research has shown that a DNA-based test is accurate for diagnosing fungal pneumonia caused by Pneumocystis jirovecii in people with weakened immune systems.
A major UK patient trial of a new biomarker testing protocol for sepsis, led by University of Manchester researchers, has shown it is possible to safely stop antibiotic treatment earlier than current care.
Research delivered through the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) has contributed to improved diagnostic guidelines for identifying and managing asthma, announced by NICE last week.
New research from the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) has shown the chance of being correctly diagnosed with asthma varies widely depending on which national or international guidelines are followed.
Researchers at The University of Manchester in collaboration with Manchester University NHS Foundation Trust are launching a new Cystic Fibrosis Innovation Hub to accelerate the development of new tests and treatment approaches for lung infections.